Insulet Corporation en las noticias
Dispositivos médicos innovadores para la diabetes
Tamtam encontró 20 artículos recientes sobre Insulet Corporation.
- Insulet Reports Q2 2026 Results: Full Earnings Call Transcript
- Insulet Corp Share Price - PODD, RNS News, Articles, Quotes, & Charts (NASDAQ:PODD)
- Barclays Starts Insulet Corporation (PODD) at Equalweight
- Ascensia Diabetes Care Expands Strategic Alliance with Insulet Corporation by Signing Commercial Agreement
- Insulet Corp. stock outperforms competitors on strong trading day
- Insulet (PODD) CFO Flavia Pease has 1,882 shares withheld for vesting taxes at $130.79 each.
- Insulet (PODD) Reworks Debt Terms, Is It Still Trading At A Discount?
- PODD Should I Buy
- (PODD) and the Role of Price-Sensitive Allocations
- A director receives 141 stock units instead of cash compensation at Insulet (PODD).
- Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
- Important Notice to Long-Term Shareholders of Beta Bionics,
- Insulet to Announce Third Quarter 2026 Financial Results on November 4, 2026
- Insulet (NASDAQ:PODD) Offers Affordable Growth With Strong Fundamentals
- Net current asset value per share of Insulet Corporation – HAN:GOV
- Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says
- Insulet Corp. stock underperforms Monday when compared to competitors
- Insulet Sees Emerging Headwinds From New Market Entrants in 2027, 2028, Oppenheimer Says
- PODD Investors Have Opportunity to Lead Insulet Corporation Class
- Bronstein, Gewirtz & Grossman, LLC Encourages Insulet Corporation (PODD) Stockholders to Inquire about Securities Investigation
Artículos recopilados por Tamtam y conservados cuando tratan sobre la empresa, del más reciente al más antiguo. Cada uno enlaza con su fuente.
¿Vendes a empresas como Insulet Corporation?
Tamtam encuentra las empresas que encajan con tu cliente ideal, investiga cada cuenta y te dice a quién contactar y cuándo.
Encontrar empresas similares